28-01-2013, 03:40 PM
Biochip Technology
[attachment=48632]
APPLICATIONS
Identification of infectious disease or
biological warfare agents in the field
as well as in hospitals and other
laboratories.
• Protein assays
• Pathogen detection (bacteria,
viruses, parasites, protozoa)
• Host immune profiling
• Chemical agents
• Gene detection
• Functional enzymes
• PCR/amplification
BENEFITS
• Easy sample preparation and
standard operating protocols
suitable for use in the field.
• Portable biochip reader
smaller than a lunchbox
• Reusable biochips
• Fully automated software for
identifying and reporting
agents
• Readily usable by first
responders, military personnel,
medical technicians
• Environmental and medical
applications
• Chips can be tailored to
individual user needs, and
mass-produced cost effectively
• Unlimited PCR multiplexing
capability from a single
sample and test
• Simultaneous spatial
resolution of thousands of
diagnostic tests from a single
sample
ABOUT ARGONNE
TECHNOLOGY TRANSFER
Argonne National Laboratory is committed
to developing and transferring
new technologies that meet industry’s
goals of improving energy efficiency,
reducing wastes and pollution, lowering
production costs, and improving
productivity. Argonne’s industrial
research program, comprised of leadingedge
materials research, cost-saving
modeling, and unique testing and
analysis facilities, is providing solutions
to the challenges that face U.S.
manufacturing and processing industries
Argonne’sBIOCHIP system:
• Provides a universal platform for both protein and nuclear acid
immobilization
• Immobilized molecules are strongly bound to the gel and retain
their biological function
• Demonstrates specific molecular interactions.
• Has no detectable non-specific binding to the gel matrix.
• Versatile design and manufacturing process allows chips to be
produced for many different purposes.
[attachment=48632]
APPLICATIONS
Identification of infectious disease or
biological warfare agents in the field
as well as in hospitals and other
laboratories.
• Protein assays
• Pathogen detection (bacteria,
viruses, parasites, protozoa)
• Host immune profiling
• Chemical agents
• Gene detection
• Functional enzymes
• PCR/amplification
BENEFITS
• Easy sample preparation and
standard operating protocols
suitable for use in the field.
• Portable biochip reader
smaller than a lunchbox
• Reusable biochips
• Fully automated software for
identifying and reporting
agents
• Readily usable by first
responders, military personnel,
medical technicians
• Environmental and medical
applications
• Chips can be tailored to
individual user needs, and
mass-produced cost effectively
• Unlimited PCR multiplexing
capability from a single
sample and test
• Simultaneous spatial
resolution of thousands of
diagnostic tests from a single
sample
ABOUT ARGONNE
TECHNOLOGY TRANSFER
Argonne National Laboratory is committed
to developing and transferring
new technologies that meet industry’s
goals of improving energy efficiency,
reducing wastes and pollution, lowering
production costs, and improving
productivity. Argonne’s industrial
research program, comprised of leadingedge
materials research, cost-saving
modeling, and unique testing and
analysis facilities, is providing solutions
to the challenges that face U.S.
manufacturing and processing industries
Argonne’sBIOCHIP system:
• Provides a universal platform for both protein and nuclear acid
immobilization
• Immobilized molecules are strongly bound to the gel and retain
their biological function
• Demonstrates specific molecular interactions.
• Has no detectable non-specific binding to the gel matrix.
• Versatile design and manufacturing process allows chips to be
produced for many different purposes.